Historic marker for first black female Indiana pharmacist
Whitaker grew up in the Pinkston settlement, a free black community just west of Ferdinand. After completing a pharmacy course, Whitaker earned her license in 1909 to practice in Gary, Indianapolis and Ferndinand.
'She did everything with kindness, and I think that's an important lesson to carry on today,' said Kathy Tretter. 'She did everything that she could do to make her world and this world a better place.'
The town commemorated her accomplishments with a marker in front of the Wollenmann House on Main Street. Dozens gathered to celebrate, including U.S. Representative Mark Messmer, who says this is a great way to remember Whitaker, especially during a time when it wasn't easy for her.
'It just shows the interest that the people have in the history of Ferdinand and the history of the people who made this community great and the people that contributed to the society in a big way,' he said. 'It shows the broad range of support of the community overall from all over the county and all over southwest Indiana.'
Ceremony speaker included Dr. John Clark from the University of South Florida's Taneja College of Pharmacy. Dr. Clark says he does not usually attend events like these, but after hearing Whitaker's story, he made the trip.
'Some of the women that have made big contributions throughout the history of pharmacy are often overlooked and overrated,' he said. 'So, I decided I wanted to be here just for that. To be inspired by everything that she's done and all her accomplishments.'
Town officials say they hope the marker is not the last of its kind and hope to see more in the future.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease
The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated's (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older. Brinsupri is the first and only FDA-approved treatment for NCFB, a chronic lung condition characterized by permanently widened and damaged airways (bronchi), leading to persistent mucus production, recurrent infections, and difficulty breathing. There are approximately 500,000 people in the U.S. diagnosed with NCFB. The approval is based on data from the Phase 3 ASPEN and Phase 2 WILLOW ASPEN, patients taking Brinsupri 10 mg or 25 mg had a 21.1% and 19.4% reduction in the annual rate of exacerbations, respectively, as compared to placebo. Both dosage strengths of Brinsupri also met several exacerbation-related secondary endpoints, including significantly prolonging the time to first exacerbation and significantly increasing the proportion of patients remaining exacerbation-free over the treatment period. Patients who received Brinsupri 25 mg experienced a statistically significantly less decline in lung function, as measured by forced expiratory volume in one second (FEV₁) after using a bronchodilator, at week 52. The safety profile for adult patients with NCFB in WILLOW was generally similar to ASPEN, except for a higher incidence of gingival and periodontal adverse reactions in WILLOW. In parallel, applications for brensocatib with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) have been accepted, and the company plans to file in Japan in 2025. Commercial launches are anticipated in 2026, pending approval in each territory. Price Action: INSM stock is up 6.20% at $119.89 at the last check on Tuesday. Read Next:Photo: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? INSMED (INSM): Free Stock Analysis Report This article FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Trump's BLS Pick Calls For Suspension Of Monthly Jobs Report: Data 'Needs To Be Fixed Immediately'
E.J. Antoni, the economist tapped by President Donald Trump to lead the Bureau of Labor Statistics and an architect of the Heritage Foundation's Project 2025, suggested the agency should suspend monthly jobs reports in a Tuesday television appearance. Antoni appeared on Fox Business Tuesday morning to discuss Trump's lack of confidence in the Bureau's monthly job data. 'How on earth are businesses supposed to plan – or how is the Fed supposed to conduct monetary policy – when they don't know how many jobs are being added or lost in our economy? It's a serious problem that needs to be fixed immediately,' Antoni told FOX Business. Suspending Job Reports: A Risky Proposition Trump nominated Antoni to the position after his unprecedented firing of former BLS Chief, Erika McEntarfer, on Aug. 1. The Bureau's July jobs report showed nonfarm payrolls rising by 73,000, far below economists' estimates of 110,000. The report also included a revision of May and June's tallies, down by over 100,000 each. Similar revisions were observed during the Biden Administration. 'Until it is corrected, the BLS should suspend issuing the monthly job reports but keep publishing the more accurate, though less timely, quarterly data,' Antoni added. 'Major decision-makers from Wall Street to D.C. rely on these numbers, and a lack of confidence in the data has far-reaching consequences.' Can Data Integrity Survive Political Pressure? Trump called the jobs report 'rigged' and 'fake' following his firing of McEntarfer. Top economists dismissed Trump and Antoni's insinuations and reiterated that attempts to erode the independence of reporting agencies could sow distrust in markets. '[Suspending monthly jobs reports] would [be] a serious mistake in my estimation. It would only fuel critiques of a politicization of job market data and likely result in volatility across asset classes,' RSM US chief economist Joe Brusuelas told Axios. Withholding or fabricating economic data is a common practice observed in many authoritarian regimes, such as the Soviet Union during the 1980s. The Dangers Of Distrust In Economic Data University of Michigan professor Justin Wolfers described Antoni as unqualified for the position in a post on X. 'Antoni finished grad school 5 years ago at Northern Illinois with no obvious distinction, his dissertation is meh, and involved no research on labor markets or data collection, he has never published a paper, and his life's work has earned 1 citation,' Wolfers said. 'This record would be insufficient to earn a job as a junior staffer at BLS.' Also Read:Photo: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Trump's BLS Pick Calls For Suspension Of Monthly Jobs Report: Data 'Needs To Be Fixed Immediately' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
18 minutes ago
- Yahoo
Scott Bessent addresses explosive ‘WWE' clash with Elon Musk in West Wing - and if he gave him a black eye
Treasury Secretary Scott Bessent has addressed reports that he had an explosive argument with Elon Musk in the West Wing earlier this year — and responded to rumors that he gave a black eye to the world's richest man. Bessent clashed with Musk in April over choices for next acting leader of the Internal Revenue Service, according to The Atlantic and subsequent media reports. The pair reportedly traded jabs and fired off expletives near the Oval Office. One witness described the fight as 'two billionaire, middle-aged men thinking it was WWE in the hall of the West Wing,' Axios reports. MAGA ally Stephen Bannon even told The Washington Post the pair exchanged blows. Musk rammed his shoulder into Bessent's rib cage 'like a rugby player,' and Bessent hit him back, Bannon recounted. Multiple people then intervened to break up the fight, the Post reported. Weeks later, Musk arrived at the White House with a black eye. Bessent, in a lengthy interview with Bloomberg published Monday, addressed what had happened with Musk but offered few details. He did, however, confirm he didn't give the SpaceX founder a black eye. 'I can 100 percent say I did not give him the black eye,' Bessent said. Musk told reporters he got the black eye from 'horsing around' with his five-year-old son, 'Lil X.' He offered the explanation at a May press conference that marked the end of his tenure as a special government employee leading the Department of Government Efficiency. 'I said go ahead and punch me in the face and he did,' the billionaire said. White House Press Secretary Karoline Leavitt addressed reports that the altercation turned physical in June, explaining she wouldn't have described it as a 'fistfight.' 'It was definitely a moved on from it,' she said. The April incident began after Musk and Bessent made their respective cases to Trump about who should be the new acting IRS commissioner, the Post reported. Trump ultimately sided with Bessent's choice. After the discussion, Musk and Bessent walked into a hallway outside the Oval Office and started exchanging insults, according to the Post. Bessent then brought up that Musk, as the leader of DOGE, had not been successful in carrying out his promise to cut $1 trillion in government spending. 'Scott said, 'You're a fraud. You're a total fraud,'' Bannon told the Post. The fight then turned physical as the pair approached the national security office, and after witnesses intervened, Musk was shuffled out of the West Wing, according to the Post. 'President Trump heard about it and said, 'This is too much,'' Bannon added. Bessent, a 62-year-old from South Carolina, was confirmed as Trump's treasury secretary in January after working for years as a top hedge fund manager. Bessent's father was the founder of a real estate firm, and his prominent family can trace its roots back to 17th century French Huguenots, Bloomberg reports. The treasury secretary previously addressed the clash in June, telling the Pod Force One podcast that he and Musk share a similar goal despite their differences. 'We have had disagreements, but we both want to get to the same place,' Bessent said. 'We both want to eliminate the waste, fraud and abuse in government.' 'The Silicon Valley mode of operation is move quickly and break things. I always say here at Treasury we move deliberately and fix things,' he added. 'I think Elon probably fancies himself more of a Viking. I think I'm more of a ninja.'
